Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  31 results for ""Porphobilinogen""

Your Filters

Content Provider : Points of View Reference Source
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 08/04/2021.

Record details

Read Online Read More Add to Saved list
×

Alnylam Pharmaceuticals Inc Conference Call to Discuss FDA Approval of GIVLAARI (Givosiran) - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 11/20/2019.

Record details

Read Online Read More Add to Saved list
×

Alnylam Pharmaceuticals Inc to Present Givosiran Phase 3 Data at the European Association for the Study of the Liver (EASL) International Liver Congress Conference Call - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 04/13/2019.

Record details

Read Online Read More Add to Saved list
×

Q4 2018 Alnylam Pharmaceuticals Inc Earnings Call - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 02/07/2019.

Record details

Read Online Read More Add to Saved list
×

Alnylam Pharmaceuticals Inc 2018 R&D Day - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 12/06/2018.

Record details

Read Online Read More Add to Saved list
×

Alnylam Pharmaceuticals Inc to Discuss Givosiran Interim Analysis Topline Data - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 09/27/2018.

Record details

Read Online Read More Add to Saved list
×

2018 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 07/24/2018.

Record details

Read Online Read More Add to Saved list
×

Q1 2018 Alnylam Pharmaceuticals Inc Earnings Call - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 05/03/2018.

Record details

Read Online Read More Add to Saved list
×

Alnylam Pharmaceuticals Inc to Discuss New Results from the Phase 1 and Phase 1/2 openlabel extension (OLE) Studies of Givosiran - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 04/14/2018.

Record details

Read Online Read More Add to Saved list
×

Event Brief of Alnylam Pharmaceuticals Inc Provides Pipeline Update on Fitusiran and Givosiran Investigational RNAi Therapeutic Programs Conference Call - Final

  • Source: Fair Disclosure Wire (Quarterly Earnings Reports). 09/07/2017.

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  31 results for ""Porphobilinogen""